| Allan Reine, M.D. | Chief Executive Officer | FY2025 | |
| Keith Gottesdiener | Former Chief Executive Officer | FY2025 | |
| Ann Lee, Ph.D. | FY2025 | ||
| Jeremy Duffield, M.D., Ph.D., FRCP | Former Chief Scientific Officer | FY2025 |
4 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.